When it comes to medical research and advancement, we usually hear about the results of a successful study or a new drug in the latter stages of a clinical trial. Rarely does the media report on trials gone wrong or the unethical aspects of medical research. This is starting to change. A May 16 New York Times article, "Drug Trials Hide Conflicts for Doctors," presented a scathing view of the patient recruitment process, the result of a 10-month investigation. The report highlights the disturbing trend of pharmaceutical companies that offer doctors financial incentives to recruit patients in a timely fashion.
Clinical Trial Methods Attracting Closer Media Scrutiny of Patient Recruitment
You might also be interested in:
- Most Effective Online Newsrooms ‘Hybrids’ That Serve the Media and Consumers Alike
- 5 Questions to Ask Before Measuring Your Content Marketing Campaigns
- 6 Ways to Integrate Employees Into Your Organizational Messaging
- 4 Steps to a Winning Social Media Narrative
- Despite Surge in Visual Storytelling, Text Articles Lead in Engagement